2025 was a powerful year for CAS-One IR. As it closes, we hope you can take a minute and reminisce with us some of the achievements. We have updated the % of treatments per organ, total centers and treatments, and more. Of course we have a collection of pictures as well. See the full infographic here cascination.com/en/news/cas-… The final Top Case of 2025 was an immediate re-ablation of an HCC in segment II. AblaSure and the re-ablation workflow helped identify, and quickly re-treat, a portion of a tumor and margin that was not met with the first try. Thanks to Marc-Antoine JEGONDAY and the team from CHU de Rennes (Rennes, FR). Read the full case report here cascination.com/en/blog/imme… We end the year just below 40 publications. 2025 brought in new evidence in ECT, quantitative ablation assessment, and ultrasound vs CAS-One IR (the latter pushing LTP below 5%!). We invite you to review our full list of publications here cascination.com/en/publicati…

CAS-One IR: Now with an increased device database integrated into our software. Stop guessing. Plan on the screen. CAS-One IR integrates 5’211 configurations of ablation parameters from 130 trusted ablation devices in the field. Find the complete list here: hubs.li/Q03Yjf-B0 With devices such as RF, MW, Cryo, IRE and ECT, CAS-One IR visualizes estimated ablation volumes from relevant device parameters such as active tip area, power, and time settings and within the patient's CT and MRI scan. We thank all of the device manufacturers in helping us aim towards 100% of margins, for all patients.

The QA Team at Inselspital has been crucial CTAS-One IR users from the early days- especially Anja Lachenmayer. Earlier this year, they passed the 1,000 patients treated mark. We thank them for their dedication to excellence in the aim of reaching 100% of margins for all patients. Along the road they have provided feedback and insights into how to improve CAS-One IR, as well as published multiple studies that are some of the most important evidence supporting Quality Ablation with CAS-One IR. We look forward to the next 1000!

Last week CAS-One IR was nearby in Auvergne-Rhône-Alpes at the AFPPE conference in Grenoble, France. Nearly 100 radiographers attended from around the country and attended multiple, in-depth hands-on demonstrations with CAS-One IR. Lesion segmentation, smart margin, ablation confirmation, and re-ablation were specifically discussed in detail – as the mindset is changing away from “navigation” and more to aiming to cover 100% of margins in 100% of patients. We are confident these positive interactions will lead to some new Quality Ablation centers in France in 2026! Thanks to Melissa GOLIN and Philippe Mathieu for leading the way in France

Dr. AbdulRahman Alvi from Ministry of National Guard Health Affairs (MNGHA) Hospital (and King Abdul Aziz Medical CIty) in Riyadh has performed nearly 20 procedures with CAS-One IR in his department led by DR. SHAKER ALSHEHRI. In the past, the cases were mostly microwave liver ablations, and some challenging biopsies, but today after a difficult ablation case, he had a second patient where he placed three gold marker fiducials high up in the liver dome. Both cases finished before lunchtime. Of all of the different cases, he says "Using CAS-One IR is way faster than our current workflow - the advantages are numerous but the ability to re-plan and re-ablate to ensure margins are met is perhaps the most powerful. I suspect our recurrence rates have been dropping rapidly" Following the in-person support from Thijs Stoker and Stijn Van Hertem during the first 10 cases, Dr. Alvi is now performing cases with remote support. Thanks of course to our partner IntelMed for the ongoing collaboration in Saudi Arabia. kholoud hassan Zyad Alrasheedi Najib HANNOUCH

AS-One IR was invited by the Medlife Group to be present in Brasov, Romania (a must visit beautiful city!) during a MedLife event. Demonstrations were given to the administrstion of the MedLife Group – of course the most interest was in planning and ablation confirmation with AblaSure of Liver Tumors, but kidney cryoablation was also a hot topic. Thanks to our esteemed partner Kral Medical Solutions showing off the AI-driven power of CAS-One IR, organized and supported such an interesting event.

CAS-One IR has been used in MSK indications from the beginning. Dr. Carlo Tappero from HFR Fribourg last week did again another osteoid osteoma in the 5th metatarsal - carefully fixating the foot and putting the markers on was no problem. The arm and aiming device can easily hold and keep a bone drill stable. Look for more details in an upcoming Top Case. Carlo Ted Steijn Thijs

Yr wythnos diwethaf – daeth CAS-One IR i Gymru! For those not fluent in Welsh, we are happy to welcome The Grange University Hospital (Aneurin Bevan University Health Board) to Quality Ablation! This project moved very quickly, and we are thankful to the team led by IRs Chris Chick, Chris Williams, and Nimit Goyal. Read more here : cascination.com/en/news/cas-…

Nearly 12,000 patients have been treated globally with CAS-One IR, and last week we were very proud to recognize Dr. Marie Beermann, Dr. Jacob Freedman and the entire team at Danderyds Sjukhus for having treated 1,500 of those patients! Their dedication, and ongoing belief in Quality Ablation is admirable as they have been a partner from the very beginning. and we look forward to the future, together. Stefan Weber Trine Bergwall Margrethe Kallestad Rasmussen Ted Farwell

Rise of the machines, velvet divorces, GPT-4 in IR, BOREALIS... The titles of the scientific talks at this year's Cardiovascular and Interventional Radiological Society of Europe (CIRSE) are riveting! It is the biggest IR event of the year globally, and for us also at CASCINATION. Our 4th Annual CIRSE Preview Blog Post is here: cascination.com/en/news/the-… Always one of our most popular articles. Enjoy. (Do you notice something new about the CAS-One IR platform?)

New ablation intel unlocked: Now there are nearly 40 publications featuring CAS-One IR – the latest coming from two hospitals in Belgium – Antwerp University Hospital (UZA) and Erasme Hospital – Université libre de Bruxelles. They conducted a retrospective cohort study comparing Ultrasound with CT-guided CAS-One IR in patients with imaging-confirmed HCC. The CAS-One IR group had superior local control and 12-month progression-free survival, particularly in anatomically challenging lesions. Read the full text (link in comments) to learn why the authors advocate stereotactic CT guidance for achieving better ablation outcomes in HCC ejso.com/article/S0748-7983(…